

House
File
2589
-
Enrolled


House
File
2589


AN
ACT


CONCERNING
THE
MEDICAL
CANNABIDIOL
ACT
AND
MARIJUANA.


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:



Section
1.
Section
96.5,
Code
2020,
is
amended
by
adding
the



following
new
subsection:



NEW
SUBSECTION


.
14.
Marijuana
or
controlled
substance
use
in



the
workplace
——
disqualified.



a.
For
purposes
of
this
subsection,
unless
the
context



otherwise
requires:



(1)
“Controlled
substance”
means
the
same
as
defined
in



section
124.101.





(2)
“Marijuana”
means
the
same
as
defined
in
section
124E.2.



b.
If
the
department
finds
that
the
individual
became





House
File
2589,
p.
2


separated
from
employment
due
to
ingesting
marijuana
in
the



workplace,
working
while
under
the
influence
of
marijuana,
or



testing
positive
for
any
other
controlled
substance,
for
which



the
individual
did
not
have
a
current
prescription
or
which
the



individual
was
otherwise
using
unlawfully,
under
a
drug
testing



policy
pursuant
to
section
730.5
or
any
other
procedures



provided
by
federal
statutes,
federal
regulations,
or
orders



issued
pursuant
to
federal
law.



c.
A
disqualification
under
this
subsection
shall
continue



until
the
individual
has
worked
in
and
has
been
paid
wages
for



insured
work
equal
to
ten
times
the
individual’s
weekly
benefit



amount,
provided
the
individual
is
otherwise
eligible.



Sec.
2.
Section
124E.2,
subsection
2,
paragraph
i,
Code



2020,
is
amended
to
read
as
follows:



i.
Untreatable


Chronic
pain.



Sec.
3.
Section
124E.2,
subsection
2,
Code
2020,
is
amended



by
adding
the
following
new
paragraphs:



NEW
PARAGRAPH


.
j.
Severe,
intractable
autism
with



self-injurious
or
aggressive
behaviors.



NEW
PARAGRAPH
.
k.
Post-traumatic
stress
disorder.



Sec.
4.
Section
124E.2,
subsections
5
and
6,
Code
2020,
are



amended
to
read
as
follows:



5.
“Health
care
practitioner”
means
an
individual
licensed



under
chapter
148
to
practice
medicine
and
surgery
or



osteopathic
medicine
and
surgery
,
a
physician
assistant





licensed
under
chapter
148C,
an
advanced
registered
nurse



practitioner
licensed
under
chapter
152,
or
an
advanced



practice
registered
nurse
under
chapter
152E,


who
is
a



patient’s
primary
care
provider
or
a
podiatrist
licensed



pursuant
to
chapter
149


.
“Health
care
practitioner”
shall
not



include
a
physician
assistant
licensed
under
chapter
148C
or



an
advanced
registered
nurse
practitioner
licensed
pursuant
to





chapter
152
or
152E
.



6.
“Medical
cannabidiol”
means
any
pharmaceutical



grade
cannabinoid
found
in
the
plant
Cannabis
sativa
L.
or



Cannabis
indica
or
any
other
preparation
thereof
that
has





a
tetrahydrocannabinol
level
of
no
more
than
three
percent



and
that
is
delivered
in
a
form
recommended
by
the
medical



























House
File
2589,
p.
3


cannabidiol
board,
approved
by
the
board
of
medicine,
and



adopted
by
the
department
pursuant
to
rule.



Sec.
5.
Section
124E.2,
Code
2020,
is
amended
by
adding
the



following
new
subsections:



NEW
SUBSECTION


.
4A.
“Employee”
means
a
natural
person
who



is
employed
in
this
state
for
wages
by
an
employer.



NEW
SUBSECTION


.
4B.
“Employer”
means
a
person
who
in
this



state
employs
for
wages
an
employee.



NEW
SUBSECTION


.
5A.
“Laboratory”
means
the
state
hygienic



laboratory
at
the
university
of
Iowa
in
Iowa
City
or
any
other



independent
medical
cannabidiol
testing
facility
accredited



to
standard
ISO/IEC
17025
by
an
international
organization



for
standards-approved
accrediting
body,
with
a
controlled



substance
registration
certificate
from
the
United
States
drug



enforcement
administration
and
a
certificate
of
registration



from
the
board
of
pharmacy.
For
the
purposes
of
this
chapter,



an
independent
laboratory
is
a
laboratory
operated
by
an



entity
that
has
no
equity
ownership
in
a
medical
cannabidiol



manufacturer.



NEW
SUBSECTION


.
5B.
“Marijuana”
means
any
derivative
of



marijuana
including
but
not
limited
to
medical
cannabidiol.



NEW
SUBSECTION


.
7A.
“Total
tetrahydrocannabinol”



means
eighty-seven
and
seven-tenths
percent
of
the



amount
of
tetrahydrocannabinolic
acid
plus
the
amount
of



tetrahydrocannabinol.



Sec.
6.
Section
124E.4,
subsection
1,
unnumbered
paragraph



1,
Code
2020,
is
amended
to
read
as
follows:



Subject
to
subsection
7
,
the
department
may
approve
the





issuance
of


issue
a
medical
cannabidiol
registration
card
by



the
department
of
transportation
to
a
patient
who:



Sec.
7.
Section
124E.4,
subsection
1,
paragraph
d,



unnumbered
paragraph
1,
Code
2020,
is
amended
to
read
as



follows:



Submits
an
application
to
the
department,
on
a
form
created



by
the
department,
in
consultation
with
the
department
of





transportation,
that
contains
all
of
the
following:



Sec.
8.
Section
124E.4,
subsection
1,
paragraph
f,
Code



2020,
is
amended
by
striking
the
paragraph.



Sec.
9.
Section
124E.4,
subsection
2,
unnumbered
paragraph
















House
File
2589,
p.
4


1,
Code
2020,
is
amended
to
read
as
follows:



A
medical
cannabidiol
registration
card
issued
to
a
patient



by
the
department
of
transportation


pursuant
to
subsection
1



shall
contain,
at
a
minimum,
all
of
the
following:



Sec.
10.
Section
124E.4,
subsection
2,
paragraph
b,
Code



2020,
is
amended
by
striking
the
paragraph.



Sec.
11.
Section
124E.4,
subsection
3,
unnumbered
paragraph



1,
Code
2020,
is
amended
to
read
as
follows:



For
a
patient
in
a
primary
caregiver’s
care,
subject
to



subsection
7
,
the
department
may
approve
the
issuance
of


issue



a
medical
cannabidiol
registration
card
by
the
department
of





transportation
to
the
primary
caregiver
who:



Sec.
12.
Section
124E.4,
subsection
3,
paragraph
b,



unnumbered
paragraph
1,
Code
2020,
is
amended
to
read
as



follows:



Submits
an
application
to
the
department,
on
a
form
created



by
the
department,
in
consultation
with
the
department
of





transportation,
that
contains
all
of
the
following:



Sec.
13.
Section
124E.4,
subsection
3,
paragraph
c,
Code



2020,
is
amended
by
striking
the
paragraph.



Sec.
14.
Section
124E.4,
subsection
4,
unnumbered
paragraph



1,
Code
2020,
is
amended
to
read
as
follows:



A
medical
cannabidiol
registration
card
issued
by
the



department
of
transportation


to
a
primary
caregiver
pursuant
to



subsection
3
shall
contain,
at
a
minimum,
all
of
the
following:



Sec.
15.
Section
124E.4,
subsection
4,
paragraph
b,
Code



2020,
is
amended
by
striking
the
paragraph.



Sec.
16.
Section
124E.4,
subsection
6,
Code
2020,
is
amended



by
striking
the
subsection.



Sec.
17.
Section
124E.5,
subsections
2
and
6,
Code
2020,
are



amended
to
read
as
follows:



2.
The
medical
cannabidiol
board
shall
convene
at
least





twice
but
no
more
than
four
times


per
year.



6.
The
medical
cannabidiol
board
may
recommend
a
statutory



revision
to
the
definition
of
medical
cannabidiol
contained
in





this
chapter
that
increases
the
tetrahydrocannabinol
level
to



more
than
three
percent,
however,
any
such
recommendation
shall





be
submitted
to
the
general
assembly
during
the
regular
session



of
the
general
assembly
following
such
submission.
The
general




















House
File
2589,
p.
5


assembly
shall
have
the
sole
authority
to
revise
the
definition



of
medical
cannabidiol
for
purposes
of
this
chapter
.



Sec.
18.
Section
124E.6,
subsection
4,
Code
2020,
is
amended



by
striking
the
subsection
and
inserting
in
lieu
thereof
the



following:



4.
A
medical
cannabidiol
manufacturer
shall
contract
with



a
laboratory
to
perform
spot-check
testing
of
the
medical



cannabidiol
produced
by
the
medical
cannabidiol
manufacturer



as
provided
in
section
124E.7.
The
department
shall
require



that
the
laboratory
report
testing
results
to
the
medical



cannabidiol
manufacturer
and
the
department
as
determined
by



the
department
by
rule.
If
a
medical
cannabidiol
manufacturer



contracts
with
a
laboratory
other
than
the
state
hygienic



laboratory
at
the
university
of
Iowa
in
Iowa
City,
the



department
shall
approve
the
laboratory
to
perform
testing



pursuant
to
this
chapter.



Sec.
19.
Section
124E.7,
subsection
1,
Code
2020,
is
amended



by
striking
the
subsection
and
inserting
in
lieu
thereof
the



following:



1.
A
medical
cannabidiol
manufacturer
shall
contract
with



a
laboratory
to
perform
spot-check
testing
of
the
medical



cannabidiol
produced
by
the
medical
cannabidiol
manufacturer
as



to
content,
contamination,
and
consistency.
The
cost
of
all



laboratory
testing
shall
be
paid
by
the
medical
cannabidiol



manufacturer.



Sec.
20.
Section
124E.9,
Code
2020,
is
amended
by
adding
the



following
new
subsections:



NEW
SUBSECTION


.
13.
A
medical
cannabidiol
dispensary



shall
employ
a
pharmacist
or
pharmacy
technician
licensed
or



registered
pursuant
to
chapter
155A
for
the
purpose
of
making



dosing
recommendations.



NEW
SUBSECTION


.
14.
A
medical
cannabidiol
dispensary
shall



not
dispense
more
than
a
combined
total
of
four
and
one-half



grams
of
total
tetrahydrocannabinol
to
a
patient
and
the



patient’s
primary
caregiver
in
a
ninety-day
period,
except
as



provided
in
subsection
15.



NEW
SUBSECTION


.
15.
A
medical
cannabidiol
dispensary



may
dispense
more
than
a
combined
total
of
four
and
one-half



of
total
tetrahydrocannabinol
to
a
patient
and
the
patient’s







House
File
2589,
p.
6


primary
caregiver
in
a
ninety-day
period
if
any
of
the



following
apply:



a.
The
health
care
practitioner
who
certified
the
patient
to



receive
a
medical
cannabidiol
registration
card
certifies
that



patient’s
debilitating
medical
condition
is
a
terminal
illness



with
a
life
expectancy
of
less
than
one
year.
A
certification



issued
pursuant
to
this
paragraph
shall
include
a
total



tetrahydrocannabinol
cap
deemed
appropriate
by
the
patient’s



health
care
practitioner.



b.
The
health
care
practitioner
who
certified
the
patient
to



receive
a
medical
cannabidiol
registration
card
certifies
that



the
patient
has
participated
in
the
medical
cannabidiol
program



and
that
the
health
care
practitioner
has
determined
that
four



and
one-half
of
total
tetrahydrocannabinol
in
a
ninety-day



period
is
insufficient
to
treat
the
patient’s
debilitating



medical
condition.
A
certification
issued
pursuant
to
this



paragraph
shall
include
a
total
tetrahydrocannabinol
cap
deemed



appropriate
by
the
patient’s
health
care
practitioner.



Sec.
21.
Section
124E.11,
subsection
1,
paragraph
b,



subparagraph
(1),
subparagraph
divisions
(a)
and
(c),
Code



2020,
are
amended
to
read
as
follows:



(a)
To
authorized
employees
or
agents
of
the
department
and





the
department
of
transportation
as
necessary
to
perform
the



duties
of
the
department
and
the
department
of
transportation





pursuant
to
this
chapter
.



(c)
To
authorized
employees
of
a
medical
cannabidiol



dispensary,
but
only
for
the
purpose
purposes
of
verifying
that



a
person
is
lawfully
in
possession
of
a
medical
cannabidiol



registration
card
issued
pursuant
to
this
chapter
and
that
a





person
has
not
purchased
total
tetrahydrocannabinol
in
excess



of
the
amount
authorized
by
this
chapter


.



Sec.
22.
Section
124E.11,
subsection
1,
paragraph
b,



subparagraph
(1),
Code
2020,
is
amended
by
adding
the
following



new
subparagraph
division:



NEW
SUBPARAGRAPH
DIVISION


.
(e)
To
a
health
care



practitioner
for
the
purpose
of
determining
whether
a
patient



seeking
a
written
certification
pursuant
to
section
124E.3
has



already
received
a
written
certification
from
another
health



care
practitioner.













House
File
2589,
p.
7


Sec.
23.
Section
124E.12,
subsection
7,
Code
2020,
is



amended
to
read
as
follows:



7.
Notwithstanding
any
law
to
the
contrary,
the
department,



the
department
of
transportation,


the
governor,
or
any
employee



of
any
state
agency
shall
not
be
held
civilly
or
criminally



liable
for
any
injury,
loss
of
property,
personal
injury,
or



death
caused
by
any
act
or
omission
while
acting
within
the



scope
of
office
or
employment
as
authorized
under
this
chapter
.



Sec.
24.
NEW
SECTION


.
124E.20
Observational
effectiveness



study.



The
department
may
conduct
an
observational
effectiveness



study
in
cooperation
with
patients
and
health
care



practitioners
and
pursuant
to
rules
of
the
department
in
order



to
study
the
effectiveness
of
medical
cannabidiol
in
the



treatment
of
debilitating
medical
conditions.



Sec.
25.
NEW
SECTION


.
124E.21
Employer
regulation
of



marijuana
use.



1.
Nothing
in
this
chapter
shall
require
an
employer



to
permit
or
accommodate
the
use,
consumption,
possession,



transfer,
display,
transportation,
distribution,
sale,
or



growing
of
marijuana
in
the
workplace.



2.
Nothing
in
this
chapter
shall
prohibit
an
employer
from



implementing
policies
restricting
the
use
of
marijuana
by



employees
for
the
purpose
of
promoting
workplace
health
and



safety.



3.
Nothing
in
this
chapter
shall
prohibit
an
employer



from
including
in
a
contract
with
an
employee
a
provision



prohibiting
the
use
of
marijuana.



4.
Nothing
in
this
chapter
shall
prohibit
an
employer



from
establishing
and
enforcing
a
zero-tolerance
drug
policy



or
a
drug-free
workplace
by
use
of
a
drug
testing
policy
in



accordance
with
section
730.5
or
any
other
procedures
provided



by
federal
statutes,
federal
regulations,
or
orders
issued



pursuant
to
federal
law.



Sec.
26.
NEW
SECTION


.
124E.22
Regulation
of
marijuana



use
by
government
medical
assistance
programs,
private
health



insurers,
and
other
entities.





Nothing
in
this
chapter
shall
require
a
government



medical
assistance
program,
private
health
insurer,
workers’








House
File
2589,
p.
8


compensation
carrier,
or
self-insured
employer
providing



workers’
compensation
benefits
to
reimburse
a
person
for
costs



associated
with
the
medical
use
of
marijuana.



Sec.
27.
NEW
SECTION


.
124E.23
Regulation
of
marijuana
use



on
property.



Nothing
in
this
chapter
shall
require
a
person
that
owns,



occupies,
or
controls
a
property
to
allow
the
use,
consumption,



possession,
transfer,
display,
transportation,
distribution,



sale,
or
growing
of
marijuana
on
or
in
that
property.



Sec.
28.
NEW
SECTION


.
124E.24
Limitation
of
liability.



Nothing
in
this
chapter
shall
create
any
claim,
cause
of



action,
sanction,
or
penalty,
for
discrimination
or
under



any
other
theory
of
liability,
under
chapter
216
or
any



other
provision
of
law,
based
on
an
act,
omission,
policy,
or



contractual
provision
permissible
under
this
chapter
including



but
not
limited
to
refusing
to
hire,
discharging,
disciplining,



discriminating,
retaliating,
or
otherwise
taking
any
adverse



employment
action
against
a
person
with
respect
to
hiring,



tenure,
or
any
terms,
conditions,
or
privileges
of
employment.



Sec.
29.
NEW
SECTION


.
124E.25
Cannabis-derived
products



——
exemption.



This
chapter
shall
not
apply
to
any
cannabis-derived



investigational
product
or
cannabis-derived
product
approved
as



a
prescription
drug
medication
by
the
United
States
food
and



drug
administration.



Sec.
30.
NEW
SECTION


.
124E.26
Applicability.



The
provisions
of
this
chapter
apply
notwithstanding
any



other
provision
of
law
to
the
contrary.



Sec.
31.
PROTECTION
OF
FEDERAL
FUNDING.
The
department



of
public
health
shall
request
guarantees
from
the
agencies



of
the
federal
government
providing
funding
to
educational



and
long-term
care
facilities
that
facilities
with
policies



allowing
patients
to
possess
medical
cannabidiol
on
the
grounds



of
the
facilities
consistent
with
chapter
124E
or
allowing



facility
staff
to
administer
medical
cannabidiol
to
a
patient



shall
not
lose
eligibility
for
any
federal
funding
due
to
such



policies.



Sec.
32.
TRANSITION
PROVISIONS.
A
medical
cannabidiol





registration
card
issued
prior
to
July
1,
2020,
remains








House
File
2589,
p.
9


effective
and
continues
in
effect
as
issued
for
the



twelve-month
period
following
its
issuance.



______________________________


PAT
GRASSLEY


Speaker
of
the
House


______________________________


CHARLES
SCHNEIDER


President
of
the
Senate


I
hereby
certify
that
this
bill
originated
in
the
House
and


is
known
as
House
File
2589,
Eighty-eighth
General
Assembly.


______________________________


MEGHAN
NELSON


Chief
Clerk
of
the
House


Approved
_______________,
2020
______________________________


KIM
REYNOLDS


Governor

